Press release
Bleeding Disorder Treatment Market to reach USD 26,177 Million - Risk-adjusted numbers with COVID-19 analysis change scenario
The Global Bleeding Disorder Treatment Market is expected to grow at a CAGR of around 7.8% from 2022 to 2030 and reach the market value of over US$ 26,177 Million by 2030.North America and Europe are projected to dominate the global bleeding disorder treatment market due to their affordability and accessibility to healthcare facilities. Furthermore, the patient awareness of bleeding disorders, as well as government and private-sector treatment campaigns, support the growth of the bleeding disorder treatment market. The growth of the bleeding disorder care industry is fueled by favorable reimbursement plans coupled with insurance. Asia-Pacific, on the other hand, is expected to grow at a rapid rate in the coming years. Rising prevalence of bleeding disorders witnessed among patients and availability of medications or treatment to treat these conditions drive the bleeding disorder treatment market.
DOWNLOAD SAMPLE PAGES OF THIS REPORT@ https://www.acumenresearchandconsulting.com/request-sample/2514
Market Dynamics
High investments in R&D activities pertaining to the development of recombinant factors coupled with improvements in the technology used for treating bleeding disorders among patient acts as a burgeoning factor for the growth of global bleeding disorder treatment market. Also, global bleeding disorder treatment market is driven by rising number of diagnosed patients suffering from bleeding disorders worldwide and government initiatives in developed economies towards the establishment of wide network of diagnosis and treatment centers for the patient pool suffering from a bleeding disorder.
Emerging markets offer lucrative opportunities for the growth of global bleeding disorder treatment market. However, high treatment cost for bleeding disorder treatment products coupled with limited reimbursement policies is expected to hinder the growth of this market during the forecast period.
VIEW TABLE OF CONTENT OF THIS REPORT@ https://www.acumenresearchandconsulting.com/bleeding-disorder-treatment-market
Segmental Outlook
Bleeding disorder treatment market is segmented based on the type and drug class. By type, the market is segmented as hemophilia A, hemophilia B, and Von Willebrand Disease (vWD). Based on drug class, the market is segmented as Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrate, antifibrinolytic, desmopressin, fibrin sealants, and others.
Based on type, Hemophilia A segment dominated the bleeding disorder treatment market in the past and is projected to continue the same trend in the forecast period. This is attributed to rising prevalence rate allied with rising prevalence of disease treatment and medication available in the global market for bleeding disorder treatment. Apart from that, recombinant coagulation factor concentrates will hold a significant share for its dominance over bleeding disorder treatment market. Lower associated infection risk and high investment in R&D by prominent players will have a positive influence for the growth of bleeding disorder treatment market.
In addition, the Food and Drug Administration (FDA) approves new products, which helps the bleeding disorder treatment market to grow to its full potential. In May 2020, FDA approved Coagulation Factor VIIa (Recombinant)-jncw for Hemophilia treatment. The approval is based on data from a clinical study evaluating coagulation factor VIIa (recombinant)-jncw in 27 patients with hemophilia A or B with inhibitors who had experienced a total of 465 mild or moderate bleeding episodes and three severe bleeding episodes. Approx. 86% of mild or moderate bleeding episodes were treated successfully with both lower and higher doses (75 mcg/kg and 225 mcg/kg) of coagulation factor VIIa (recombinant)-jncw, and all three severe bleeding episodes were treated successfully with the higher dose.
Competitive Landscape
The major players involved in the bleeding disorder treatment market involve Sanofi SA, Swedish Orphan Biovitrum AB, Janssen Pharmaceuticals, Inc., Baxter International Inc., Pfizer Inc., Genentech, Inc., CSL Behring, Novo Nordisk, and among others.
Browse Upcoming Market Research Reports@ https://www.acumenresearchandconsulting.com/forthcoming-reports
Some of the key observations regarding bleeding disorder treatment industry include:
• In September 2018, Sanofi SA announced receiving approval for rare blood clotting disorder treatment. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) and recommend the approval of "caplacizumab" that is prescribed to adults suffering from thrombotic thrombocytopenia purpura (aTTP)
• In February 2020, Novo Nordisk, announced launching of new product namely, "ESPEROCT®" The newly launched product is the company's long acting recombinant factor V111 product for the prevention and treatment of bleeding individuals suffering from Hemophilia A. The company reported that the new product proved to be safe and well tolerated across all clinical trials.
• In June 2020, Pfizer Inc., in collaboration with Sangamo Therapeutics, Inc. announced updated follow-up data from the Phase 1/2 Alta study of "giroctocogene fitelparvovec". The study is an investigational gene therapy for patients with severe Hemophilia patients. The new drug is generally well absorbed and shows significant results related to tolerance in the patients.
INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/2514
BUY THIS PREMIUM RESEARCH REPORT - https://www.acumenresearchandconsulting.com/buy-now/0/2514
201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bleeding Disorder Treatment Market to reach USD 26,177 Million - Risk-adjusted numbers with COVID-19 analysis change scenario here
News-ID: 2851072 • Views: …
More Releases from Acumen Research and Consulting

Compact High Pressure Laminates Market to Reach USD 9.6 Billion by 2032, Driven …
The Compact High Pressure Laminates Market is gaining remarkable momentum as industries across construction, interior design, healthcare, and commercial applications increasingly adopt durable, stylish, and sustainable surfacing solutions. Valued at USD 5.9 Billion in 2023, the market is projected to reach USD 9.6 Billion by 2032, reflecting a steady compound annual growth rate (CAGR) of 5.6%.
Get Free PDF Sample Pages of This Report: https://www.acumenresearchandconsulting.com/request-sample/3646
Compact High Pressure Laminates, or Compact HPL,…

Culture Media Market Set to Surge Beyond USD 17.32 Billion by 2032, Driven by Ad …
Culture Media Market Poised for Robust Expansion Amid Biotechnology Boom
The Culture Media Market has emerged as a cornerstone of modern life sciences, enabling researchers and manufacturers to cultivate, identify, and preserve microorganisms and cells for critical applications. From drug discovery to diagnostic testing, culture media plays an indispensable role in advancing human health and biotechnology.
According to Acumen Research and Consulting, the global Culture Media Market size was valued at USD…

Green Energy Market Size to Hit USD 2.41 Trillion by 2032 | Key Trends, Share & …
The global Green Energy Market is experiencing unprecedented momentum. According to Acumen Research & Consulting, the market reached USD 1.15 trillion in 2023 and is forecast to grow at a CAGR of 8.7% from 2024 to 2032, reaching approximately USD 2.41 trillion by 2032. This Green Energy Market Analysis highlights the sweeping scale of investment and innovation driving the sector forward.
Green Energy Market Size & Growth Snapshot
• 2023 market size: USD…

Pipeline Safety Market: Ensuring Integrity in Energy Transportation
The global pipeline safety market is a critical component of energy infrastructure, ensuring the safe transportation of oil, gas, and other hazardous materials over vast distances. With rising demand for energy and increasing regulatory scrutiny, pipeline safety has become paramount in maintaining the integrity of these vital systems. This report delves into the factors driving the market, current trends, and future projections for this rapidly evolving industry.
Pipeline Safety Market Overview…
More Releases for Bleeding
Growth Of Bleeding Disorder Testing Market Driven By Increasing Clinical Trials: …
The Bleeding Disorder Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Bleeding Disorder Testing Market?
The bleeding disorder testing market size has increased strongly in recent years. It will rise from $14.99 billion in 2024 to $16.23 billion…
Rise In The Incidences Of Upper Gastrointestinal Bleeding: Key Factor Driving Th …
The Gastrointestinal Bleeding Treatment Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Gastrointestinal Bleeding Treatment Devices Market Size During the Forecast Period?
Recent years have seen a robust growth in the market size of devices used in the treatment of gastrointestinal…
Key Trend Reshaping the Bleeding Disorder Testing Market in 2025: Innovative Gen …
What industry-specific factors are fueling the growth of the bleeding disorder testing market?
The bleeding disorder testing market is poised for growth, buoyed by the rise in clinical trials. Clinical trials, which test the safety and efficiency of new medical care methods, therapies, drugs, or technology in humans, are increasing due to advancements in medical research, more healthcare innovation investment, and an upsurge in demand for novel treatments and therapies. Bleeding…
Transforming the Bleeding Disorder Testing Market in 2025: Growth Of Bleeding Di …
What Is the Expected Size and Growth Rate of the Bleeding Disorder Testing Market?
The market size for bleeding disorder testing has witnessed robust growth in recent years. The market value is projected to increase from $14.99 billion in 2024 to a whopping $16.23 billion in 2025, registering a compound annual growth rate (CAGR) of 8.3%. The rate of growth recorded in the historic period is associated with factors such as…
Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of…
Global Cyclic Heavy Menstrual Bleeding Market
Global Cyclic Heavy Menstrual Bleeding Market
Heavy menstrual bleeding (HMB) is one of the most common debilitating gynecologic disorders that is affecting women of reproductive age. Increasing incidence rate drives the growth of the cyclic heavy menstrual bleeding market. Rising cases of uterine fibroids and polyps boost the growth of cyclic heavy menstrual bleeding. In addition, effective treatment cost and easy availability of treatment options plays a significant role in…